CURRICULUM VITAEPARVAIZ A KOUL MD, FACP (USA) FCCP (USA), FICP, FRCP (Pulmonary Medicine) (London)

RG score 50.22H-index 34

Current Position:

Professor & Head, Internal & Pulmonary Medicine Registrar, University of SKIMSChief, Divisions of Geriatrics/Infectious Disease/RheumatologyNodal Officer, HIV/AIDS, JK SACSChairman, State Task Force/Core Committee, RNTCP program, J&KChairman, Operational Research, RNTCP, J&KHead, Clinical Research, SKIMS

Address:Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, Soura, Srinagar 190011, J&K (India)Tel: (91)-194-2401353, Ext: 2256Fax: (91)-194-2403470 Email: parvaizk@gmail.comWeb: www.skims.ac.in

EDUCATION & TRAINING

1984 Govt. Medical College, SrinagarUniversity of Kashmir, J&K, India M.B.B.S

1/20/83 to 1/19/84 Internship GMC, Srinagar, Kashmir

1/20/84 to 31/1/1985 Housemanship, Medicine SMHS Hospital, Srinagar, Kashmir

2/1/85 to 5/30/88 Trainee Resident for Sheri Kashmir Institute of Medical Postgraduate Course (MD) Sciences, Srinagar, Kashmir, India

in Internal Medicine 30/5/86 to 16/12/88 Resident, Internal Medicine SheriKashmir Institute of Medical

Sciences, Srinagar, Kashmir, India11/95 to 12/95 Bronchoscopy Fellow LRS Institute of TB & Lung Disease

Page

18

New Delhi.

04/2005 Fellow, Pulmonary & Sleep NorthShore LIJ Health SystemMedicine Long Islands, New York

27/01/05 Certified by Infection Control Learning Institute in Infection control and Barrier Precautions for New York State Licensure (score of 100% )

June 2012 Fellowship of the Royal College of Physicians (London)

FACULTY APPOINTMENTS

January 2008 till date Professor & Chair MedicineChief of Internal & Pulmonary Medicine, SKIMS, Kashmir (India)

May 2007 to June 2012 Head, Accident & Emergency, SKIMS,Kashmir

June 30, 2001 till January 2008 Senior Consultant (Addl Prof./Professor) of Internal & > Six Years Pulmonary Medicine & Head, Medical Division Ist

Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir

Nov.27, 1995 to Jun 29, 2001(Five Years & 9 months) Associate Professor (Reader/Sr. Consultant) of Internal &

Pulmonary Medicine, Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir

May 17, 1991 to Nov.26, 1995 Assistant Professor of Internal and [Four Years & six months] Pulmonary Medicine

Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir

HOSPITAL OR OTHER PROFESSIONAL APPOINTMENTS

Current Position

01/08- Chief, Internal Medicine/Pulmonary Medicine/Infectious Diseases/Geriatric Medicine SKIMS, Srinagar, J&K (India)

2

Page

18

01/08- Program Director, Residency & Fellowship Program, SKIMS, Srinagar (J&K), India.

01/08- Chief of Medicine, SKIMS Medical College, Bemina, Kashmir (India)

01/08- Program Director, Medical Technology Courses

05/12 - Chair, Clinical Research Department, SKIMS

05/12- Chair, Human Resource Development, SKIMS, Srinagar, Kashmir (India)

10/99-05/12 Chief of Bronchoscopic & Sleep Services,Department of Internal & Pulmonary Medicine,Sheri Kashmir Institute of Medical Sciences, Srinagar,Kashmir.

04/2000/- National level Source Person for training health personnel (faculty level) in AIDS for AIDS Control Programme by NACO, New Delhi.

01/2011/- Nodal Officer for AIDS and HIV, NACO India01/2011/- Nodal Officer & Head, Regional Geriatric Center, SKIMS01/2011/- Chairman, Core Committee on RNTCP, J&K01/11/- Chairman, OR Committee, RNTCP, J&K1-11/- Coordinator, Machinery and Equipment, Purchase

Committee, SKIMS, Srinagar1/11 till date Member, Purchase Committee, SKIMS, Srinagar

Prior Positions

03/05-09/05 Addl. Professor & Head, Medicine, SKIMS, Srinagar (India)

03/05-09/05 Chief of Medicine & Pulmonary Medicine, SKIMS Medical College, Bemina, Kashmir.

Hospital Appointments

May 1990 till May 1991 Senior Registrar and Incharge, Accident &[One Year] Emergency

Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir

Dec. 17,1988 to May 1990 Senior Resident (Senior Registrar),

3

Page

18

[One year & 4 months] Medicine & Allied Specialties, Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir.

May 31 to Dec.16, 1988 MD Resident in Medicine (Registrar) [Seven months] Internal Medicine & Allied Specialties

Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir

MEMBERSHIP OF MAJOR PROFESSIONAL SOCIETIES

MEMBER, GOVERNING COUNCIL

Indian Chest SocietyIndian Society for Bronchology (Joint Secretary)

MEMBER

National Technical Advisory Group on Immunization (NTAGI), Government of India since 2013.

MEMBER

Member, World Association of Medical Editors, 2012

Indian Academy of Geriatrics, 2012

American College of Chest Physicians, FCCP since Dec 2009.

American College of Physicians, FCCP since May 2004 (Awarded Direct Fellowship 2004)

European Respiratory Society, since 2004.

Indian College of Physicians, Fellow since 2005

Association of Physicians, India since 2001 (General Secretary of J&K Chapter)

Indian Medical Association, Life member since 2003

Indian Chest Society

National College of Chest Physicians, India

Indian Society for Study of Lung Cancer

World Association of Medical Editors.

EXECUTIVE MEMBER

Influenza Foundation of India from 2012.

Asia Pacific Alliance for Influenza (APACI)

4

Page

18

Collaborator, Global Burden of Disease from 2015.

Indian Society for Study of Lung Cancer from 2012.

Global Influenza Initiative (GIHSN Network) France from 2015.

HONORS/AWARDS (Reverse Chronological Order)

1. OA Sama oration Award at NAPCON, Ahmedabad October, 2018

2. Bill & Mellinda Gates Award for ICID 2016 at Hyderabad, March 1-5, 2016.

3. “Distinguished Services Award” for Influenza. Influenza Foundation of India, APACI, GSI

April 13, 2016.

4. Honor scroll, Geriatric Society of India for contribution to development of Geriatric

Society of India guidelines for Vaccination in the elderly, 2015.

5. Pariyawaran Mitra Award, Environmental Medical Association of India, June 2014

6. KC Mohanty Oration, Academy of Respiratory Medicine, July 2013.

7. Pfizer Human Initiative 2004 Award (International fellowship)

8. “Marquis Who’s Who in the World” 2000.

9. Best Paper Award at APICON (Association of Physicians India conference) 1996

10. Recipient of certificate of Merit academic excellence for Medicine (1982)

11. Recipient of Merit scholarship- Govt. of Jammu & Kashmir

12. European Respiratory Society Gold sponsorship for ERS, 2008.

13. Fellowship of American College of Physicians 2004 (Direct Fellowship Award)

14. Best Referee Award Indian Chest Society, 2011 for Lung India.

5

Page

18

ACADEMIC PROFESSIONAL SERVICES at various academic institutions

A. University of SKIMS, Srinagar

2008/- present Incharge, Residency Program, Medicine & Allied Specialties

2002-present Interview Panel, Medicine Fellows/Postgraduate Candidates

2008-present Interview Panel, Medicine Faculty candidates

2001-present Examiner, Doctoral program in Medicine

2008-present Examiner, Medical Technology Course (BSc & MSc courses)

2010/- Examiner, Doctoral program in Immunology & Molecular Medicine

2011/- Coordinator, Machinery and Equipment Purchase

2011/- Chair, Medical Grand Rounds

B. Postgardaute Institute of Medical Education & Reseach, Chandigarh, Services

2008/- External Examiner, Doctoral Program (MD) , Medicine

2010/- External Examiner, Doctoral Program (DM), Pulmonary Medicine

C. University of Kashmir & Government Medical College, Srinagar, Kashmir Services

2005/- Examiner, Doctoral program in Medicine

2004/- Evaluater, Undergraduate program (MBBS)

D. Maulana Azad Medical College, New Delhi Services

2011/- Examiner, MD (Medicine)

6

Page

18

E. University of Delhi, New Delhi Services

2011/- Examiner MD (Medicine)

F. University of Rajasthan Services

2015/- Examiner MD (Chest Medicine)

G. University of Kashmir & Government Dental College Services

2007/- Examiner, Medicine (Dental program)

H. SKIMS Medical College Service

2009 Interview Panel, Medicine, Faculty candidates

2009-10 Interview Panel, Fellow/Residency candidates

2001-present Examiner, Undergraduate program (MBBS)

I. Univeristy of Gujarat 2014/- Examiner for MD/DNB chest Medicine

J. All India Institute of Medical Sciences, New Delhi2019 Examiner for PhD in Pulmoanry and Sleep Diorders

K. J&K AIDS Society (National AIDS Control Organization) Services

2007/08 Selection Panel, Medical Staff Candidates

L. National Board of Examinations, New Delhi

2009 Infrastructural and Accredition Inspector for DNB program for Army Cantonment Hospital, Badami Bagh

7

Page

18

HOSPITAL ASSIGNMENTS:

2008-present Faculty Appointment, SKIMS University and SKIMS Medical College

2008-present Interview, Senior Residency Fellowship candidates at SKIMS University

2007-present Member, Library Committee, SKIMS, Srinagar

2008-present Member, Hospital Drug Purchase Committee, SKIMS, Srinagar

2008-present Member, Dean’s Committee, SKIMS, Srinagar

2008-present Member, Academic Council, SKIMS, Srinagar

2008-present Head, Pulmonary Medicine, SKIMS, Srinagar

2010/-present Member, Research Cell, SKIMS, Srinagar

2011/-present Coordinator, Equipment Procurement for SKIMS

2011/-present Convenor, Lab Audit, SKIMS

2012/- present Chairman, Clinical Research Department, SKIMS

2012/- present Chief, Human Resource Development, SKIMS

2012/- 2016 Head, Advanced Genetic Center, SKIMS

OTHER PROFESSIONAL SERVICES

2012/- till date Chair, Indian Society of Critical Care (J&K Chapter)

2004/- present General Secretary, Association of Physcians, India, J&K State Chapter

2000/- present Source Person for training health personnel (faculty level) in AIDS for AIDS Control

8

Page

18

1990 Chief of the Special Epidemic Study Group, to study the epidemic of gastroenteritis that struck Ladakh in August, 1990 (on request of the Government of Jammu and Kashmir).

COMMUNITY SERVICES

Expert for Doctor-online for answering online phone queries regarding Sleep Related Disorders including Obstructive Sleep Apnea, Influenza, Chest Disroders, etc

Served as expert on health awareness programmes by Television Centre, Srinagar on Hepatitis E; AIDS, Noise Pollution, Sleep disorders, SARS and that on AIDS conducted by Radio Kashmir, Srinagar, Kashmir

Expert for answering queries to various questions in the leading daily of the state “The Greater Kashmir”in the weekly column in the magazine ‘Sensor’

Organized community level awareness program on SARS- the menace and measures.

Participated in health awareness programmes for the Community and Schools on SMOKING AND HEALTH organized by the Cancer Society of Kashmir.

Participated in multiple programmes conducted by the Cancer Society of Kashmir on AIDS for common masses and school children.

Resource person for imparting teaching of various aspects of HIV infection and AIDS under the auspices of NACO and gave multiple lectures in this regard. Also trainer for Nurses, paramedic and residents.

WORLD COPD Day 2009/2010

DOCTORS DAY 2009

SPIROMETRY CAMP CUM AWARENESS 2008-2010

9

Page

18

TEACHING SERVICES:

05/1988- present SheriKashmir Institute of Medical Sciences, Srinagar (India) Medical students/Residents/Medicine fellows

05/1991-present SKIMS Medical College, Bemina, Kashmir (India) Medical Students/Interns/Residents

International Level

Faculty at various international conferences on Influenza, Respiratory Infections, COPD, ILD, Hydatid Disease, etc. Delivered faculty level lectures in USA, Germany, Austria, France, China, Dubai, Abu Dhabi, Saudi Arabia, Indonesia, Malaysia, Singapore, Canada, South Korea and Australia.

National LevelFaculty level participation in Pulmonary Medicine conference/WorkshopsFaculty Resource for Influenza meetings (National and International)Faculty, Vadodara Chest Meeting, Vadodara, India, 2009, 2015Faculty, Hinduja Respiratory Medicine Update, Hinduja Hospital, Mumbai, Nov.2009-2015Faculty, ROAD (Refresher course on Obstructive Airway Disease), Pune, India 2010Faculty, National College of Chest Physicians/Indian Chest Society Meeting (2003 till date)Faculty, Baroda Chest Group meeting since 2014.Faculty, PGI Respiratory Meet since 2005Faculty, BRONCOCON since 2002Faculty at Indian Association of Critical Care. Trainer of Trainers, RNTCP program on TuberculosisTrainer of trainers, AIDS an HIV infection, JK SACS/NACO

Local

Initiator and co-coordinator for Medicine lecture series. (didactic lectures on Internal and Pulmonary Medicine topics and bed side demonstration of clinical procedures in Pulmonary Medicine)

10

Page

18

Curriculum Development

Development and Upgradation of Core curriculum for MD/MBBS/Medical Technology courses.Guidelines development committee for the Indian Chest Society, Association of Physicians of India, Indian Association for Bronchology, NTAGI (Government of India), Geriatric Society of India.

SUPERVISORSHIP/CO-SUPERVISORSHIP OF POSTGRADUATE STUDENTS

Mentored the following fellows in Internal Medicine on the research projects shown against each:

Name of Postgraduate/Fellow Thesis/ Research project topic

Primary Supervisor1. Dr. Aijaz Nabi Koul CT Appearances of Pulmonary Hydatid Disease. 2. Dr. Fayaz A Hakim Profile of infections in acute leukemics.3. Dr. Arshad Andrabi Double blind, placebo controlled study of

steroids in typhoid fever with DIC)4. Dr. Khalil Knajwal Percutaneous aspirarion In lung hydatid disease5. Dr. Anurag Singh Praziquantel as a scolicidal drug in pulmonary

hydatid disease6. Dr. Sajjad Geelani Benign Jaundice in the Kashmiri Community.7. Dr. Fayaz Gul Parray Role of steroids in acute exacerbation of COPD.8. Dr. Satish Koul Incidence of lung cancer in Kashmir9. Dr. Irfan Ahmad Comparison of Formoterol versus Formoterol/

Tiotropium combination in stable COPD patients10. Dr. Mushtaq Ahmad Epidemiology of lung cancer in Kashmir-200511. Dr. Mubashir Ahamd Epidemilogical correlates of lung cancer in

Kashmir.12. Dr. Hilal Ahmad Rather p-16 hypermethylation in various body

specimen from lung cancer patients in Kashmir13. Dr. Hilal Ahmad Dar Long term mortality in COPD patients after an

Exacerbation.

14. Dr. Shabir Ahmad Osteoporosis in patients with COPD, role of

inflammation and vitamin D status

15. Dr. Arif Nabi COPD in the bakers of Kashmir.

16. Dr Abid Bhat Comorbidities in COPD in Urban Kashmir

17. Dr Riyaz Ahmad Etiological and Microbiological profile of

11

Page

18

Pneumonia in Kashmir

18. Dr Anil Kumar Profile of thrombocytopenias in Kashmir

19. Dr Shafat Shamas Profile of ILD in Kashmir

20. Dr. Abid Ahmad Thrombolysis in loculated pleural effusion.

21. Dr Mohd Ramzan Vitamin D levels and AECOPD

22. Dr. Syed Mohsin Variables of hookah-smoking and COPD

23. Dr Saleem Javid Randomized trial of a combination of Vitamin C,

Thiamine and Steroids in Sepsis.

24. Dr Abid Mufti Variables in success of NIV in COPD

25. Dr. Sayyar Ahmad Follow up of Radiology in Community Acquired

pneumonia

26. Dr Haseeb Mahajan Follow up of BOLD 2 patients with COPD

27. Dr Zahoor Mortality and variables BOLD 2 study

28. Dr Salim Javed Double blind study of a combination of Vitamin C,

steroids and thiamine in patients with septic shock.

Co-supervisor

1. Dr Ruqqaya Internstitial Lung Disease (Role of Pathology)2. Dr.Fayaz Ahmad Bhat Haemostasis in Rheumatoid Arthritis)3. Dr.Aijaz A. Lone Albendazole as a scolicidal agent in Pulmonary

Hydatid Disease in vitro studies on human hydatid cyst fluid specimens.

4. Dr. Mohd Hayat Efficacy of Mepacrine and Praziquantel inNiclosamide Resistant Taeniasis.

5. Dr. Mushtaq A Lone Efficacy of TENS in Periarthritis of the Shoulder.6. Dr. Fayaz A Khan Comparison of methotrexate alone or in

combination with chloroquin in the managament of rheumatoid arthritis).

Supervision of Doctoral Research Programs :

*Dr. M. Ishaq Geer (PhD student in Pharmaceutical Sciences, University of Kashmir)(Adverse drug effects of commonly administered drugs in Kashmir).

12

Page

18

*Mohammad Shafi Sheikh (PhD student in Immunology & Molecular Medicine, SKIMS University): Degree awarded July 2010

(EGFR mutations in Lung cancer patients in Kashmir)

JOURNAL SERVICES

Editor, Lung India from 2012

Editorial Services for Journals

1. Editor Lung India2. Emeritus Editor Journal of Medical Sciences (2016/-)3. Editorial Board American College of Chest Physicians journal

CHEST. 4. Editor in Chief Journal of Medical Sciences (2011/2016) 5. Executive editor Journal of Medical Sciences (2008-2011)

2. Editorial board member Clinical Medicine (Open Access Journal) Libertas Academica (New Zealand)

Internet journal of Pulmonary Medicine (USA)JK PRACTITIONER (Journal of Medicine & Surgery)

Also Served as Deputy Editor of JK Practitioner for about 2 years

6. Associate Editor Journal of Medicine and Medical Sciences

7. Section Editor for “LUNG Cancer” LUNG INDIA

8. Member, World Association of Medical Editors (WAME)

Peer Reviewer Services

Emergency Medical Journal, UK JK Practitioner, India

13

Page

18

Chest (USA) The Lancet (London) Medical Science Monitor (Hungary) Journal of Medical Sciences (India) Chest Online (USA). Medicine Online British Medical Journal Pediatric Infectious Diseases (USA) Saudi Medical Journal Annals of Thoracic Medicine Lung (USA) Journal of Medical Sciences, India. Lung India Saudi Journal of Kidney Diseases &

Transplantation.

Digestive Diseases & Sciences, USA JAPI Medicine and Medical Sciences International J Public Health and

Administration Webcentral.com

Medpedia.com Annals of Saudi Medicine BMJ Open

Indian J Chest Dis Allied Science

RESEARCH GRANTS/INTERNATIONAL COLLABORATIONS/CLINICAL TRIALS

A. International Grants & Collaborative Research

1. International Research Grants: In collaboration with Dr. Stephen Walsh, Royal Free Hospital (UK), received a grant of £76753.1 for study of “Renal tubular acidosis in Kashmir and its possible link with malaria resistance” from the St. Peter Trust for Kidney, Bladder and Prostate Research (Patron HRH The Duchess of Gloucester GCVO) The disorder is a cause of recurrent hypokalemic muscular paralysis and respiratory failure in our population.

2. Collaborative partnership with Chest Research Foundation, Pune, India for conducting a study on Peak flows in Indian Adults (PERFORM study)

3. PI for BOLD study in collaboration with Imperial College, London for the Burden of Lung Disease (BOLD) study; a multicentric International study on COPD. Funded by Wellcome Trust, UK

4. Surveillance of Influenza in Kashmir under the aegis of India Influenza Program, CDC, USA and ICMR, New Delhi (PI: Parvaiz Koul)

5. Survey of Influenza and other Respiratory Viruses in Acute Exacerbation of COPD in Kashmir (India) (PI: Parvaiz Koul)In collaboration with CDC, Atlanta, Georgia

6. Site PI for Interstitial Lung Disease Registry of India, headquartered at Jaipur (PI Prof. Virendra Singh)

14

Page

18

7. Survey for Influenza in a nomadic community in the Himalayan Mountains. Funded by CDC, USA India Influenza Division.

8. Economic burden of Influenza in children. In collaboration with CDC, USA and has 2 sites at AIIMS, New Delhi and SKIMS, Srinagar

9. Influenza in the under fives. In collaboration with CDC, USA.

10. CDC funded project on the respiratory infection component of the VHF/RI biorisk mitigation in India. Site PI (Dr Parvaiz Koul) [Current]

11. University of Utah, Salt Lake City, USA. Adaptations in high altitude dwellers. PI: Parvaiz Koul [Current]

12. Site PI for Longitudenal Aging Study in India (LASI) in collaboration with University of Southern California, USA and Indian Institute of Population Studies, Mumbai. [Current]

13. Site PI for LASI-DAD study in collaboration with University of Southern California, USA and Indian Institute of Population Studies, Mumbai. [Current]

14. Influence of Climate on Respiratory Disease: Joint multi-centric Project with PGIMER, Chandigarh for study of environment on lung disease admissions.(submitted to ICMR, New Delhi). PI: Prof. Ashutosh Aggarwal. [Current]

15. Peramavir in Severe Influenza: A multi-centric study sponsored by BioCryst Pharmaceuticals, USA.

16. A Randomized double dummy, double blind, Active Controlled, Multicentric trial to compare the efficacy and safety of CSE-1034 (Ceftriaxone+Sulbacam+ EDTA) with Meropenem in infections caused by beta-lactamse (ESBL + MBL) producing Gram-negative bacteria (2015-16)

17. A phase-iV study of the safety and efficacy of Elores (Cetriaxone+Tazobactum+EDTA) in management of acute respiratory infections requiring hospitalization (current).

18. A multicenter, open-label, randomized, active-controlled, parallel group, pivotal study to investigate the efficacy, safety and tolerability, and pharmacokinetics of murepavadin combined with one anti-pseudomonal antibiotic versus two anti-pseudomonal antibiotics in adult subjects with ventilator-associated bacterial pneumonia (VABP) suspected or confirmed to be due to Pseudomonas aeruginosa (CURRENTLY ONGOING)

19. Genetic diversity of Kashmiri population in collaboration with University of Utah, Salt Lake City, Utah (USA)

20. Thrombocytopenia in Kashmiri population (Genetic basis) in collaboration with University of Utah, Salt Lake City, Utah (USA) [Current]

15

Page

18

21. BOLD-II, Study funded by Welcome Foundation, UK in collaboration with Imperial College, London.

22.

B. Institutional / National level Grants:

Following research projects were funded by SKIMS for carrying out research projects/postgraduate training programmes which are summarized as follows:

Dr. Aijaz Nabi Koul CT Appearances of Pulmonary Hydatid Disease. Dr. Fayaz A Hakim Profile of infections in acute leukemics. Dr. Arshad Andrabi Double blind, placebo controlled study of

steroids in typhoid fever with DIC) Dr. Khalil Knajwal Percutaneous aspirarion In lung hydatid disease Dr. Anurag Singh Praziquantel as a scolicidal drug in pulmonary

hydatid disease Dr. Sajjad Geelani Benign Jaundice in the Kashmiri Community. Dr. Fayaz Gul Parray Role of steroids in acute exacerbation of COPD. Dr. Satish Koul Incidence of lung cancer in Kashmir Dr. Irfan Ahmad Comparison of Formoterol versus

Formoterol/Tiotropium combination in stable COPD patients Dr. Mushtaq Ahmad (Epidemiology of lung cancer in Kashmir-2005) Dr. Mubashir Ahamd Epidemilogical correlates of lung cancer in

Kashmir. Dr. Hilal Ahmad Rather p-16 hypermethylation in various body

specimens from lung cancer patients in Kashmir Dr. Hilal Ahmad Dar Long term mortality in COPD patients after

Exacerbation. Dr. Shabir Ahmad Osteoporosis in patients with COPD

Dr. Arif COPD in the bakers of Kashmir.

Dr. Irfan Hussain Thrombocytopenia in blood donors in Kashmir.

Dr. Saleem Javid Wani Placebo controlled trial of Vitamin C, Thiamine and

hydrocortisone in patients with severe sepsis.

SCIENTIFIC COMMUNICATIONS/INVITED LECTURES/TALKS

More than 500 presentations, invited lectures and talks delivered in conferences, symposia and CME programs at the state & national level and in international conferences. Chaired many conference sessions, symposia and award sessions and acted as judge in national conferences for paper evaluation.

16

Page

18

PARTICIPATION IN CLINICAL TRIALS

1. Peramavir in Severe Influenza: A multi-centric study sponsored by BioCryst Pharmaceuticals, USA.

2. A Randomized, Double-blind, Double-dummy, Active-controlled, Multi-centre Trial to Compare the Efficacy and Safety of CSE-1034 (Ceftriaxone+ Sulbactam + EDTA) with Meropenem in Infections Caused by β – Lactamase (ESBL and MBL) producing Gram Negative Bacteria. Clinical Trial Protocol No: VRL/CSE-1034/05/2012. Sponsor: Venus Remedies

3. Phase IV study for post-marketing surveillance of a combination of Ceftriaxone + Sulbactum + EDTA for its safety and efficacy.

PUBLICATIONS (Published/In press) in Reverse Chronological Order)

Original Articles/Clinical Observations

1) Koul PA, Bhavsar A, Mir H, Simmerman M, Khanna H. Epidemiology and costs of severe acute respiratory infection and influenza hospitalizations in adults with diabetes in India. J Inefct Developing Countries 2019; 13(03):204-211.

2) Koul PA, Hussain Irfan. Chronic Obstrucive Lung Disease. In Kamath S (eds), API Textbook of Medicine. Jaypee Brothers. 2019; 1298-1307.

3) Koul PA, Nowshehri AA, Khan UH, Shah SU, Jan RA. Cost of severe exacerbation of COPD in a high burden region of North India. Annals Global Health 2019; 85(1):13;1-5 DOI: https://doi.org/10.5334/aogh.2423

4) Dhooria S, Agarwal R, Sehgal IS…..Koul PA…..Thangakunam B. Bronchoscopic lung cryobiopsy: An Indian association for bronchology position statement. Lung India. 2019 Jan-Feb;36(1):48-59.

17

Page

18

5) Koul PA in GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2019 Jan;7(1):69-89.

6) Koul PA, Potdar V, Mir H, Shauwkat M, Chadha MS. Influenza B in a temperate region of northern India 2010–2016: co-circulation of the two lineages with northern hemispherical seasonality. VirusDisease 2018 Dec;29(4):553-559.

7) Koul PA in India State-Level Disease Burden Initiative Air Pollution Collaborators. The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017. Lancet Planet Health. 2018 Dec 5. pii: S2542-5196(18)30261-4.

8) Koul PA, Mir H, Saha S, Potdar V, Chadha MS, Krishnan A. Respiratory viruses in returning Hajj & Umrah pilgrims with acute respiratory illness in 2014-2015. Ind J Med Research 2018;148:329-333.

9) Koul PA in GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789-1858.

10) Koul PA in GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923-1994.

11) Koul PA in GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159).

12) Dhooria S, Agarwal R, Dhar R….Koul PA…Ghoshal AK. Consensus Statement for the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis in Resource Constrained Settings. The Indian Journal of Chest Diseases & Allied sciences 60(2):91-119

13) Koul PA in GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for

18

Page

18

195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018 Nov 10;392:2091-2138.

14) Koul PA in GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392:1736-1788.

15) Koul PA in Community Acquired Pneumonia investigators. An international perspective on hospitalized patients with viral community-acquired pneumonia. European J Intern Med, November 2018. DOI: 10.1016/j.ejim.2018.10.020

16) Koul PA in GBD Mortality Collaborators. Global, regional, and national age-sex-specificmortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet November 2018;392:1684-1735

17) Mir H, Koul PA. Preventive pulmonology in COPD. Pulmonary Clinics of India 4, Academy of Respiratory Medicine. September 2018

18) Koul PA in GBD Lower Respiratory Infection Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infect Dis 2018 Sep 19. pii: S1473-3099(18)30310-4. doi: 10.1016/S1473-3099(18)30310-4. [Epub ahead of print]

19) Koul PA in India State-Level Disease Burden Initiative CRD Collaborators. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Global Health. September 2018. DOI:https://doi.org/10.1016/S2214-109X(18)30409-1

19

Page

18

20) Koul PA in GLIMP investigators. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018 Aug 9;52(2). pii: 1701190. doi: 10.1183/13993003.01190-2017.

21) Koul PA, Potdar V, Mir H, Chadha MS. The 2015 outbreak of Severe Influenza in Kashmir, North India:Emergence of a New Clade of A/H1N1 Influenza Virus. Plos Currents DOI: 10.1371/currents.outbreaks.519e170f2740fabd4ccd1642ff533364

22) Koul PA, Dhar R. Economic burden of Asthma in India. Lung India. 2018;35(4):281-283.

23) Koul PA in GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018 Jun 2;391(10136):2236-2271. doi: 10.1016/S0140-6736(18)30994-2. Epub 2018 Jun 1. PMID:29893224

24) Kumar S, Jan RA, Fomda BA, Rasool R, Koul PA. Utility of Procalcitonin in the Management of Hospital-Acquired Pneumonia - A Review. Current Respiratory Medicine Reviews. 2018; doi.10.2174/1573398X14666180601073756

25) Koul PA, Mir H. The biggest barrier to influenza vaccination in pregnant females in India: Poor sensitization of the care providers. Vaccine 2018 Jun 14;36(25):3569-3570. doi: 10.1016/j.vaccine.2018.04.039.

26) Kumar S, Jan RA, Fomda BA, Rasool R, Koul PA, Shah SU, Khan UH, Qadri SM, Masoodi SM, Mantoo S, Muzamil M. Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Bacterial Aetiology, Antibiotic Resistance and Treatment Outcomes: A Study From North India. Lung 2018; April: doi: 10.1007/s00408-018-0117-7

27) Parra R, Fomda BA, Jan RA, Shah SU, Koul PA. Microbial etiology of hospitalized north Indian patients with Community Acquired Pneumonia. Lung India 2018;35:108-15.

20

Page

18

28) Koul PA. Chronic hypersensitivity pneumonitis: A diagnostic and prognostic conundrum. Chest (India) 2018;8(3):6-8

29) Koul PA in GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2018 Mar;18(3):261-284.

30) Malik SA, Khan MS, Mudassar S, Koul PA. Clinical and etiological profile of hypokalaemia: A prospective study in a tertiary care hospital. Clinical Medicine and Diagnostics. 2017;(5):107-112.

31) Koul PA in Burden of Lung Disease (BOLD) Study. Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study. European Respiratory Journal 2017;50(5):pii 1700621

32) Koul PA in The India State-level Disease Burden Initiative: Health of the Nation's States - The India State-level Disease Burden Initiative. Technical Report number: ISBN 978-0-9976462-1-4, Affiliation: 11772. November 2017.

33) Koul PA In Disease Burden in India: Global Disease Burden study. Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. The Lancet 2017; 390, 10111:2437–2460

34) Koul PA, Dar HA, Jan RA, Shah SU, Khan UH. Two-year mortality in survivors of acute exacerbations of chronic obstructive pulmonary disease: A North Indian study. Lung India 2017;34(6):511

35) Bali NK, Mir H. Tantray AG, Kakru DK, Koul PA. Meningococcal carriage in College freshmen in Kashmir, North India: A single centre study. J Clin Diagnostic Research 2017; Oct; Vol 11(10): OC13-OC17

36) Grønseth R, Erdal M, Tan WC, Obaseki DO, Amaral AFS, Gislason T, Juvekar SK, Koul PA, Studnicka M, Salvi S, Burney P, Buist AS, Vollmer WM, Johannessen A; Research teams at centres. Unemployment in chronic airflow obstruction around the world: results from the BOLD study. Eur Respir J. 2017 Sep 20;50(3). pii: 1700499. doi: 10.1183/13993003.00499-2017.

37) Koul PA in GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and

21

Page

18

metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8.

38) Koul PA in GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.

39) Koul PA in GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.

40) Koul PA in GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1151-1210. doi: 10.1016/S0140-6736(17)32152-9.

41) Koul PA in GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0.

42) GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1423-1459. doi: 10.1016/S0140-6736(17)32336-X. Epub 2017 Sep 12.

43) Koul PA. Vaccines with rapid trun around are the need of the hour. (E-letter) Science July 2017.

22

Page

18

44) Koul PA. Preventive Pulmonology: Role of vaccines. Pulmonary Clinics of India. 2017 Jul 7;3:168-185.

45) Bhat SA, Mir MM, Koul PA. Osteoporosis in COPD: Are Bones Brittle in COPD? J Pulm Respir Med 201;7: 417. doi: 10.4172/2161-105X.1000417

46) Koul PA in GBD Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine August 16, 2017. http://dx.doi.org/10.1016/S2213-2600(17)30293-X

47) Townend J, Minelli C, Mortimer K, Obaseki DO, Al Ghobain M, Cherkaski H, Denguezli M, Gunesekera K, Hafizi H, Koul PA, Loh LC, Nejjari C, Patel J, Sooronbayev T, Buist SA, Burney PGJ. The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J. 2017 Jun 1;49(6). pii: 1601880. doi: 10.1183/13993003.01880-2016

48) Koul PA in GBD 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet. 2017 May 18. pii: S0140-6736(17)30818-8.

49) Koul PA in GBD 2015 Tobacco collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017 Apr 5. pii: S0140-6736(17)30819-X. doi: 10.1016/S0140-6736(17)30819-X

50) Riyaz MS, Rather MK, Koul PA. Diabetes in Immigrant Tibetan Muslims in Kashmir, North India. J Immigr Minor Health. 2017 Mar 3. doi: 10.1007/s10903-017-0558-8.

51) Pai M, Koul P. India’s fight against tuberculosis: How can chest physicians help? Lung India 2017;34(2):120-122.

52) Tashi T, Scott Reading N, Wuren T, Zhang X, Moore LG, Hu H, Tang F, Shestakova A, Lorenzo F, Burjanivova T, Koul P, Guchhait P, Wittwer CT, Julian CG, Shah B, Huff CD,

23

Page

18

Gordeuk VR, Prchal JT, Ge R. Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin

concentration in Tibetan highlanders. J Mol Med (Berl). 2017 Feb 23. doi: 10.1007/s00109-017-1519-3.

53) Koul PA, Mir Hyder. COPD: Indian Perspective, Edition: Ist, Chapter: 13, Publisher: Shree Ram Law House, CHD, Association of Physicians India and Indian College of Physicians, Editors: Vittul K Gupta, 2017 pp.92-99

54) Cowling BJ, Caini S, Chotpitayasunondh T, Djauzi S, Gatchalian SR, Huang QS, Koul PA, Lee PI, Muttalif AR, Plotkin S; Global Influenza Initiative. Influenza in the South East Asia and the Pacific. Vaccine. 2017 Jan 9. pii: S0264-410X(16)31298-1. doi: 10.1016/j.vaccine.2016.12.064. [Epub ahead of print]

55) Koul PA, Mir H, Akram S, Potdar V, Chadha MS. Respiratory viruses in acute exacerbation of COPD. Lung India 2017;34(1):29-33.

56) Koul PA. Communicating with the patients; the heart of the art of Medicine. Lung India 2017;34:95-96.

57) Latief M, Raja W, Sofi N, Dar IA, Kasana B, Hussain M, Arshad F, Shah BA, Koul PA. Novel risk factors and early detection of anti tubercular treatment induced liver injury—Looking beyond American Thoracic Society Guidelines. The Indian journal of tuberculosis · December 2016. DOI: 10.1016/j.ijtb.2016.11.002

58) Koul PA, Bali N, Sonawane S. Knowledge, Attitude, and Behavioural Response of Corporate Employees in India towards Influenza: A Questionnaire Based Study. J Assoc Physicians India. 2016 Nov;64(11):44-50.

59) Koul PA, Mir Hyder, Saha SS, Potdar V, Chadha MS, Widdowson MA, Lal R, Krishnan A. Influenza, not MERS in pilgrims returning from Hajj and Umrah 2014-2015. J Travel Med Infect Dis 2016 Dec 6. pii: S1477-8939(16)30208-3. doi: 10.1016/j.tmaid.2016.12.002. [Epub ahead of print]

60) Koul PA. Vaccination in the prevention of community acquired pneumonia. J Assoc Physicians India 2016; suppl 12 (December): 26-31.

24

Page

18

61) Koul PA in GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1775-1812.

62) Koul PA in GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1725-1774.

63) Koul PA in GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1659-1724.

64) Koul PA in GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1603-1658.

65) Koul PA in GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1545-1602.

66) Koul PA in GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1459-1544

67) Koul PA, Hakim NA, Malik SA, Khan UH, Patel J, Gnatiuc L, Burney PG. Prevalence of chronic airflow limitation in Kashmir, North India: results from the BOLD study. Int J Tuberc Lung Dis. 2016 Oct;20(10):1399-1404.

68) Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, Singh N, Ho L, Samaria JK, Bhattacharya P, Gupta R, Chaudhari S, Singh T, Moond V, Pipavath S, Ahuja J, Chetambath R, Ghoshal AG, Jain NK, Devi HG, Kant S, Koul P, Dhar R, Swarnakar R, Sharma SK, Roy DJ, Sarmah KR, Jankharia B, Schmidt R, Katiyar SK, Jindal A, Mangal DK, Singh V, Raghu G. Interstitial Lung Disease (ILD) in India: Results of a Prospective Registry. Am J Respir Crit Care Med. 2016 Sep 29.

25

Page

18

69) Koul PA in GBD 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1813-1850.

70) Koul PA. Metabolic syndrome and COPD. Lung India. 2016 Jul-Aug;33(4):359-61

71) Koul PA in GLIMP study investigators. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Sep 1. pii: S1473-3099(16)30267-5. doi: 10.1016/S1473-3099(16)30267-5. [Epub ahead of print]

72) Downie JM, Tashi T, Lorenzo FR, Feusier JE, Mir H, Prchal JT, Jorde LB, Koul PA. A Genome-Wide Search for Greek and Jewish Admixture in the Kashmiri Population. PLoS One. 2016 Aug 4;11(8):e0160614. doi: 10.1371/journal.pone.0160614. eCollection 2016.

73) Koul PA, Ali S, Mir H, Ahmad SJ, Akram S, Bhat MA. Influenza vaccination in north Indian patients with heart failure. Indian Heart J 2016;Available July 30, 2016(Ahead of print)

74) Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, Hay SI, Mills EJ, Trickey A, Msemburi W, … Koul PA, …Murray CJ. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV. 2016 Aug;3(8):e361-87. doi: 10.1016/S2352-3018(16)30087-X.

75) Murugunathan A, Guha S, Munjal YP, Agarwal SS, Parikh KK, Jha V, Jha AK, Abeywicreme I, Tiwaskar T, Nadkar MY, Pal J, Arafat SM, Prakash A, Panda J, Ramasubramanian V, Kumari S, Jain, Ghosh MK, Koul PA.. Recommendations for Vaccination Against Seasonal Influenza in Adult High Risk Groups: South Asian Recommendations. J Assoc Physicians India (suppl): 2016; July 1: 64(7):3-11.

76) Koul PA, Jan Asif. Recurrent Pneumothorax. World Clin Pulm Crit Care Med 2016;4(2):121-31.

77) Koul PA, Bali NK, Mir H. Influenza in Indian pregnant women_ a cross sectional study. Infect Dis Obstet Gynecol. 2016;2016:1248470. doi: 10.1155/2016/1248470.

26

Page

18

78) Koul PA. Bronchoscopy: Where it helps? In Wander GS, ed Medicine Update. Association of Physicians India, Jaypee Brothers. 2016,

79) Bali NK, Farhana A, Kakru DK, Koul PA. Lower Respiratory Tract Infections in Intensive Care Units. A Four Year Study from North India. British J Biomed Sci 2016. DOI: 10.9734/BJMMR/2016/21636

80) Koul PA, Bali NK. Influenza Vaccination in India: Challenges for universal adoption.

Vaccine 07/2015; DOI:10.1016/j.vaccine.2015.07.021

81) Sharma SK……Koul PA….Consensus and evidence-based Indian initiative on obstructive sleep apnea guidelines 2014 (first edition). Lung India 07/2015; 32(4):422-33. DOI:10.4103/0970-2113.159677

82) Koul PA. Asthma COPD overlap syndrome. Pulmonary Clin India 2015; 1:

83) Shah S, Rashid A, Shah ZA, Jan RA, Khan UH, Bhat IA, Mantoo S, Shah TH, Koul PA. A disintegrin and metalloprotease 33 polymorphism association with COPD in long-term tobacco smokers of the ethnic Kashmiri population of India. Lung India. 2015 May-Jun;32(3):220-4. doi: 10.4103/0970-2113.156222.

84) Agarwal R, Dhooria S, Aggarwal AN, Maturu VN, Sehgal IS, Muthu V, Prasad KT, Yenge LB, Singh N, Behera D, Jindal SK, Gupta D, Balamugesh T, Bhalla A, Chaudhry D, Chhabra SK, Chokhani R, Chopra V, Dadhwal DS, D'Souza G, Garg M, Gaur SN, Gopal B, Ghoshal AG, Guleria R, Gupta KB, Haldar I, Jain S, Jain NK, Jain VK, Janmeja AK, Kant S, Kashyap S, Khilnani GC, Kishan J, Kumar R, Koul PA, Mahashur A, Mandal AK, Malhotra S, Mohammed S, Mohapatra PR, Patel D, Prasad R, Ray P, Samaria JK, Singh PS, Sawhney H, Shafiq N, Sharma N, Sidhu UP, Singla R, Suri JC, Talwar D, Varma S. Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Lung India. 2015 Apr;32(Suppl 1):S3-S42. doi: 10.4103/0970-2113.154517

85) Koul PA, Patel D. Indian guidelines for asthma: adherence is the key. Lung India Lung India. 2015 Apr;32(Suppl 1):S1-2. doi: 10.4103/0970-2113.154511

86) Chadha MS, Potdar VA, Saha S, Koul PA, Broor S, Dar L, Chawla-Sarkar M, Biswas D, Gunasekaran P, Abraham AM, Shrikhande S, Jain A, Anukumar B, Lal RB, Mishra AC. Dynamics of influenza seasonality at sub-regional levels in India and implications for

27

Page

18

vaccination timing. PLoS One. 2015 May 4;10(5):e0124122. doi: 10.1371/journal.pone.0124122. eCollection 2015.

87) Peasah SK, Purakayastha DR, Koul PA, Dawood FS, Saha S, Amarchand R, Broor S, Rastogi V, Assad R, Kaul KA, Widdowson MA, Lal RB, Krishnan A. The cost of acute respiratory infections in Northern India: a multi-site study. BMC Public Health. 2015 Apr 7;15:330. doi: 10.1186/s12889-015-1685-6.

88) Koul PA, Bali NK. Viral hemorrhagic fever in India. Update on Tropical Fever, 1st edited by Ashish Bhalla, 03/2015: chapter Viral hemorrhagic fevers in India: pages 150-165; Association of Physicians of India.

89) Koul PA, Mir H, Bhat MA, Khan UH, Khan MM, Chadha MS, Lal RB. Performance of rapid influenza diagnostic tests (QuickVue) for influenza A and B Infection in India. Indian J Med Microbiol. 2015 Feb;33 Suppl:26-31. doi: 10.4103/0255-0857.148831.

90) Koul PA. Ocular toxicity with ethambutol: timely recaution. Lung India. 2015 Jan-Feb;32(1):1-3. doi: 10.4103/0970-2113.148395.

91) Koul PA, Khan UH, Asad R, Yousuf R, Broor S, Lal RB, Dawood FS. Contribution of influenza to acute exacerbations of chronic obstructive pulmonary disease in Kashmir, India, 2010-2012. Infleunza Other Respir Viruses. 2015 Jan;9(1):40-42. doi:10.1111/irv.12291.

92) Gnatiuc L, Buist AS, Kato B, Janson C, Aït-Khaled N, Nielsen R, Koul PA, Nizankowska-Mogilnicka E, Obaseki D, Idolor LF, Harrabi I, Burney PG; BOLD Collaboration. Gaps in using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites. Int J Tuberc Lung Dis. 2015 Jan;19(1):21-30. doi: 10.5588/ijtld.14.0263.

93) Koul PA, Broor S, Saha S, Barnes J, Smith C, Shaw M, Chadha M, Lal RB. Differences in influenza seasonality by latitude, northern India. Emerg Infect Dis. 2014 Oct;20(10):1723-6. doi: 10.3201/eid2010.140431.

94) Koul PA, Bali NK. Clinical features and complications of tuberculosis. World Clinics Pulmonary and Critical Care Medicine: Tuberculosis, Vol 3 (N1) edited by SK Jindal, D Behera, 01/2015: chapter Clinical Features and Complications of Tuberculosis.: pages 21-45; Jaypee Brothers., ISBN: 2319-2160

28

Page

18

95) Lorenzo FR, Huff C, Myllymäki M, Olenchock B, Swierczek S, Tashi T, Gordeuk V, Wuren T, Ri-Li G, McClain DA, Khan TM, Koul PA, Guchhait P, Salama ME, Xing J, Semenza GL, Liberzon E, Wilson A, Simonson TS, Jorde LB, Kaelin WG Jr, Koivunen P, Prchal JT. A genetic mechanism for Tibetan high-altitude adaptation. Nature Genetics 2014 Sep;46(9):951-6. doi: 10.1038/ng.3067. Epub 2014 Aug 17.

96) Koul PA, Bali NK, Ali S, Mr H, et al. Poor influenza vaccination in pregnant females in north India. Int J Gynecol Obstetrics 2014. (01./2014)

97) Gupta D, Agarwal R, Aggarwal AN, Maturu VN, Dhooria S, Prasad KT, Sehgal IS, Yenge LB, Jindal A, Singh N, Ghoshal AG, Khilnani GC, Samaria JK, Gaur SN, Behera D, Jindal SK…Koul PA…Thakur S. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: joint recommendations of Indian Chest Society and National College of Chest Physicians (India). Indian J Chest Dis Allied Sci. 2014;56 Spec No:5-54.

98) Koul PA, Ara D. Pulmonary rehabilitation in COPD. In: Shankar PS, Vora A, eds. Update in Respiratory Medicine. 2014,11/2014. Academy of Respiratory Medicine. Pp65-79.

99) Koul PA, Mantoo S. Viral Pneumonia. Pulmonary Clinics of India. 2014;1:113-120.

100) Koul PA, Bhat MA, Ali S, Rahim S, Ahmad S, Masoodi SR. Influennza and Pneumococcal vaccination in patients with diabetes. J Diabetology. 2014;2:5

101) Koul PA, Mir H, Shah TH, Bagdadi F, Khan UH. Effect of pepper gas exposure on non-combatant bystanders. Journal Public Health Policy 15 May, 2014. doi:10.1057/jphp.2014.15

102) Kodgule RR, Singh V, Dhar R, Saicharan BG, Madas SJ, Gogtay JA, Salvi SS, Koul PA. Reference values for peak expiratory flow in Indian adult population using a European Union scale peak flow meter. Journal of Postgraduate Medicine. 2014 Apr-Jun;60(2):123-9. doi: 10.4103/0022-3859.132311.

103) Burney P, Jithoo A, Kato B, Janson C, Mannino D, Nizankowska-Mogilnicka E, Studnicka M, Tan W, Bateman E, Koçabas A, Vollmer WM, Gislason T, Marks G, Koul PA, Harrabi I, Gnatiuc L, Buist S; Burden of Obstructive Lung Disease (BOLD) Study. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking

29

Page

18

and poverty--a BOLD analysis. Thorax. 2014 May 1. doi: 10.1136/thoraxjnl-2014-205474. [Epub ahead of print]

104) Sharma SK, Katoch VM, Mohan A, Kadhiravan T, Elavarasi A,Ragesh R, Nischal N, Sethi P, Behera D, Bhatia M, [...], Singhal Rajinder, Soneja Manish, Subramanian Krishnnan A, T. Mohan Kumar, Thakkar Alok, Tiwari Akash, Tripathi Manjari, Tripathi Suryakant, Upadhyay Vishwanath, Varma Subhash Consensus & Evidence-based INOSA Guidelines 2014 (First edition). Ind J Med Res 2014;140(3):451-68.

105) Koul PA, Khan UH, Jan RA, Shah T, Shah SU. Tubercular osteomyelitis of the mandible in a young female. International J Mycobacteriol 01/2014. http://dx.doi.org/10.1016/j.ijmyco.2014.02.002

106) Tashi T, Feng T, Koul P, Amaru R, Hussey D, Lorenzo FR, Rili G, Prchal JT. High altitude genetic adaptation in Tibetans: No role of increased hemoglobin-oxygen affinity. Blood Cells Mol Dis. 2014 Mar 4. pii: S1079-9796(14)00009-6. doi: 10.1016/j.bcmd.2014.02.003.

107) Koul PA, Khan UH, Shah TH, Dar AM. All that wheezes is not asthma. BMJ Case Reports 02/2014; DOI:doi:10.1136/bcr-2013-202369

108) Zafar MSH, Wani JI, Karim R, Mir MM, Koul PA. Significance of Serum magnesium in the critically ill patients. International Journal of Sciences: Basic and Applied Research (IJSBAR) 01/2014; 4(1).

109) Khan UH, Mir MA, Ahmad F, Mir MH, Bali N, Lal RB, Broor SS, Koul PA. Influenza B outbreak in a nomadic population in the Himalayan Mountains. Indian J Med Res 2013;138 (December):110-113.

110) Bali NK, Fomda BA, Bashir H, Zahoor D, Lone S, Koul PA. Emergence of carbapenem-resistant Acinetobacter in a temperate north Indian State. Br J Biomed Sci. 2013;70(4):156-60.

111) Raina AH, Bhat A, Bhat FA, Changal KH, Dhobi GN, Koul PA, Raina MA, Wani FA. Pulmonary tuberculosis presenting with acute respiratory distress syndrome (ARDS): A

30

Page

18

case report and review of literature. Egyptian Journal of Chest Diseases and Tuberculosis. 2013;62:655-659.

112) Koul PA. Primary spontaneous pneumothorax and the Birt-Hogg-Dubé syndrome. J Postgrad Med. 2013 Oct-Dec;59(4):324-5.

113) Burney P, Jithoo A, Kato B, Janson C, Mannino D, Nizankowska-Mogilnicka E, Studnicka M, Tan W, Bateman E, Koçabas A, Vollmer WM, Gislason T, Marks G, Koul PA, Harrabi I, Gnatiuc L, Buist S; Burden of Obstructive Lung Disease (BOLD) Study. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysis. Thorax. 2014 May;69(5):465-73. doi: 10.1136/thoraxjnl-2013-204460. Epub 2013 Dec 18.

114) Bhat GQ, Thussu SK, Mufti S, Shah SU, Koul PA, Shah P, Khan AH, Jan RA. Correlative Study of Imprint and Crush Cytology with Histopathology in Endobronchial Growths. Journal of Cytology & Histology 2013;4:3. http://dx.doi.org/10.4172/2157-7099.1000177

115) Koul PA, Khan UH, Bhat K, Saha S, Broor S, Lal R, Chadha MS. Recrudescent Wave of A/H1N1pdm09 Influenza Viruses in Winter 2012-2013 in Kashmir, India. PLOS Currents. 2013 Sep 26. Edition 1. doi: 10.1371/currents.outbreaks.f1241c3a2625fc7a81bf25eea81f66e6.

116) Koul AN, Ahmad J, Koul PA. Moxifloxacin induced neutropenia. Scan J Infect Dis 2013

117) Koul PA, Khan UH, Jan RA, Shah SU, Qadri AB, Wani B, Ashraf M, Ahmad F, Bazaz SR. Osmotic demyelination syndrome following slow correction of hyponatremia: possible role of hypokalemia. Ind J Crit Care Med 2013;17(4):231-33.

118) Gupta D et al. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India 2013;23 (jul-Sep):228-267.

31

Page

18

119) Koul PA, Khan UH, Hussain T, Koul AN, Malik S, Shah SU, Bazaz S, Rashid W, Jan RA. High altitude pulmonary edema in Amarnath Yatris. Lung India. 2013; 23 (Jul-Sep):193-197.

120) Koul PA. Chronic Obstructive lung disease. Indian guidelines and beyond. Lung India 2013; Jul-September:175-177. (Editorial)

121) Koul PA, Khan UH, Shah TH, Bagdadi F. Skin rash and subconjunctival hemorrhage in patient with pandemic H1 N1 influenza. BMJ Case Reports. 2013. doi:10.1136/bcr-2013-010216

122) Koul PA, Ahmad F, Gurcoo SA,Khan UH, et al. Fat embolism syndrome in long bone trauma following vehicular accidents: Experience from a tertiary care hospital in north India. Lung India 04/2013; 30(2):97-102. DOI:10.4103/0970-2113.110413

123) Koul AN, Khan UH, Jan RA, Koul PA. A Giant Mantous reaction in tubercular lymphadenitis. Pak J Chest Dis 2013; February

124) Koul PA. Surgical Treatment of lung cancer: GcMAF and other considerations. Author’s Reply to letter on “Surgery in limited-stage small cell lung cancer”Lung India 2012;29(3):303-4.

125) Koul PA, Khan UH, Jan RA, Koul AN, Qadri AB. What is your diagnosis? Skin lesions in a young female with Behcet’s disease. Indian J Rheumatol 2012;

http://dx.doi.org/10.1016/j.injr.2012.04.015,.

126) Jan RA, Khan UH, Javed G, Wani KA, Mufti S, Shah SU, Qadri M, Koul PA. Behcet’s disease presenting as Intestinal ulceration with perforation. Indian J Rheumatol 2012:7(1):60-63.

127) Bali NK, Khan UH, Ahmad F, Ashraf MA, Lal RB, Koul PA. Knowledge, Attitudes and Practices about Seasonal Influenza Vaccination in Health care workers in Kashmir, India. Influenza and Other Resp Viruses 2012; DOI:10.1111/j.1750-2659.2012.00416.x

128) Koul PA. Vitamin D and respiratory infections. Journal of Medicine & Med Sciences 2012;3(2)Feb:13-14

129) Koul PA. Surgery in Limited- stage small-cell lung cancer. Lung India 2012;29:2-3.

32

Page

18

130) Koul PA, Chaouachi K. Important Clarifications about Peculiarities of Hookah Smoking and Lung Cancer in Kashmir. Asia Pacific Dis Cancer Prevention 2011;12:2145-2146.

131) Koul PA, Mufti SA, Khan UH, Jan RA. Intrathoracic gossypiboma. Interactive CardioVascular and Thoracic Surgery 2011; 1–3 doi:10.1093/icvts/ivr058

132) Koul PA, Khan UH, Sofi FA. Skin rash and pneumonia in a young male. BMJ Case Reports 2011;10.1136/bcr.07.2011.4558

133) Koul PA, Wahid A. Distal renal tubular acidosis and hypokalemic paralysis in a patient of hypothyroidism. Saudi J Kid Dis Tranplanation 2011 Sep;22(5):1014-6.

134) Geer MI, Mir JI, Koul PA. Optimizing Clinical Outcomes through Pharmaceutical Care. Physicians Academy. 2011;5(9). Available at

http://www.physiciansacademy.com/current_article_details.aspx?Id=671&CDVolume.

135) Sofi FA, Koul PA, Mufti S, Dhobi GN. Lamotrigine induced toxic epidermal necrolysis.BMJ Case Reports 2011; doi:10.1136/bcr.04.2011.4149

136) Koul PA, Hajni MR, Sheikh MA, Khan UH, Shah A, Khan Y, Ahanger AG, Tasleem RA. Hookah smoking and Lung Cancer in the Kashmir valley of the Indian subcontinent. Asian Pacific J Cancer Prevention 2011;12:519-524.

137) Koul PA, Mir MA, Bali NK, Sarkar MC, Sarkar M, Kaushik S, Khan UH, Ahmad F, Lal RB, Broor S. Pandemic and seasonal flu viruses amongst patients with acute respiratory illness in Kashmir (India). Influenza and Other Respiratory Viruses 2011; DOI:10.1111/j.1750-2659.2011.00261.

138) Lorenzo FR, Phillips JD, Nussenzveig R, Lingam B, Koul PA, Schrier SL, Prchal JL. Molecular basis of two novel mutations found in type I methemoglobinemia. Blood Cells Mol.Diseases (2011), doi:10.1016/j.bcmd.2011.01.005

139) Koul PA, Feroze Ahmad, Khan UH, Jan RA, Shah SU. Hypervitaminosis D from an endemically vitamin D deficient area. Oman Med J 2011;26 (3):201-204.

140) Koul PA, An elderly male with tubercular osteomyelitis of the chest wall.BMJ Case Reports 2011; doi:10.1136/bcr.12.2010.3638

33

Page

18

141) Koul PA, Khan U, Eachkoti R,Wani AA, Jan RA, Shah SU, Masoodi ZA, Qadri SM, Ahmad M, Ahmad A. Comparison and Agreement between venous and arterial gas analysis in cardiopulmonary patients in Kashmir valley of the Indian subcontinent. Ann Thoracic Med 2011;6 (1):33-37

142) Koul PA, Khan UH. Bronchoscopic diagnosis of a ruptured hydatid cyst in a young male with hemoptysis. J Bronchol Intervention Pulmonol 2011;18(1):61-64.

143) Koul PA, Qadri SM. Pigeon mite induced superficial lymphangitis. BMJ Case Reports 2010; doi:10.1136/bcr.09.2010.3310

144) Koul PA, Khan U, Shah S, Jan R, Wani A, Qadri A, Masoodi Z. Adult hemophagocytic lymphohistiocytosis: A 25-year experience at a tertiary care hospital. WebmedCentral INFECTIOUS DISEASES 2010;1(9):WMC00674

145) Koul PA, Koul SK, Sheikh MA, Tasleem RA, Shah A. Lung Cancer in the Kashmir Valley. Lung India 2010;12(Jul-Sep);131-137.

146) Koul PA, Singh A, Wahid A, Ahanger AG, Sofi BA. Optimal duration of preoperative antihelminthic therapy for pulmonary hydatid surgery Australia & New Zealand J Surgery 2010;80(5)May:354-357.

147) Shaffi SM, Shah MA, Bhat MA, Koul PA, Ahmad SN, Siddiqi MA. CYP1A1 Polymorphism and Risk of Lung Cancer in the Ethnic Kashmiri Population . Asia Pacific J Cancer Prevention 2009;10:651-656.

148) Koul PA, Khan UH, Sweyer James Macleods syndrome in a young female. J Med Sci 2009:

149) Jan R, Koul PA, Shah SU, Mufti SA, War FA. Kaposi’s sarcoma in a non HIV patient. Interntional J Health Sciences 2008;3:237-240.

150) Koul PA, Khan UH, Shah SU, Jan RA, Ahmad A, Masoodi Z, Qadri SM, Ahad A. Extensive pneumomediatinum in a patient of olivopontocerebellar degeneration and bronchial asthma. Internet J Pulmonary Medicine 2009;11:1

151) Sofi FA, Koul PA, Dhobi GN. Lower Limb Firomuscular dysplasis with sparing of the renal and cranial ateries: A case report. J Med Sciences-2009:8(2):115-17.

34

Page

18

152) Koul PA, Wahid A, Hilal Ahmad, Jan RA, Shah SU. Kerosene induced lung disease (unusual modes of exposure) Journal of Nutritional and Environmental Medicine 2008;17:1-6.

153) Koul PA, Wahid A, Jan RA. Long term oxygen therapy in COPD: Review of the guidelines and a Critical audit of usage in the Kashmir Valley of the Indian Subcontinent. Kashmir Med J 2008;2(1):112-118.

154) Koul PA, Wahid A, Bhat TA, Hussain T. A Whistle in the bronchus. Annals of Thoracic Medicine 2007;2:124-125.

155) Koul PA, Wahid A Lone GN, Ahmad T. A young female with a chest wall swelling. Medical Journal of Australia 2007;186 (4):213.

156) Koul PA, Jan R, Bhat T, Qadri M. Familial hypercholesterolemia – report of a case. Saudi Medical Journal 2007;28(4):628-630.

157) Koul PA, Qayoom A. Mass deworming in Kashmir: A case for a Mass Deworming Day. Br Med J (www.bmj.com September 29,2006)

158) Koul PA, Geelani SA, Mudassir S. Benign Jaundice in healthy blood donors in the

Kashmir valley of Indian subcontinent. Internet J Internal Medicine 2006;6(1).

159) Koul PA, Majid N. HIV in India: Problems galore. The Lancet June 12, 2006available at http://www.thelancet.com/journals/lancet/article/PIIS0140673606688181/comments

160) Koul PA, Ahmad A. Caesarean section amongst doctors: A dangerous trend. The Lancet, June 07, 2006. http://www.thelancet.com/journals/lancet/article/PIIS0140673606687801/comment

161) Koul PA, Kanjwal MK. Albendazole induced rupture of pulmonary hydatid cysts. Internet Journal of Pulmonary Medicine 2006; 6 (1)

162) Geer MI, Tanki SA, Koul PA, Shah MY. Pharmacovigilance at SKIMS Srinagar (J&K)- A case study. J Pharmacovigilance & Drug Safety 2005:2: 1-5.

35

Page

18

163) Koul PA, Bhat FA, Wahid A. Primary gradient renal tubular acidosis with dextrocardia presenting as hypokalemic paralysis with respiratory failure. Emerg Med J( BMJ group) 2005 Jul;22(7):528-30.

164) Koul PA. Drugs for pneumonia-geographical concerns. British Medical journal 28 Feb, 2005 Available from: http://bmj.com/cgi/eletters/330/7489/456#98470, 28 Feb 2005

165) Koul PA. Managing chronic diseases: combination of inhaler treatment in India has shown good results. Br Med Journal 2005Apr23;330(7497):964;discussion 964-5. http://bmj.bmjjournals.com/cgi/eletters/329/7462/361#70955

166) Koul PA, Iqbal J, Wahid A. A man with skin darkening and arthritis. J Med Sciences 2004;7:65-66.

167) Koul PA. Species identification in Taeniasis. The Lancet 2004:Jun 12;363(9425):1999

168) Koul PA. Guidelines for Respiratory diseases and the developing countries. British Medical Journal. Aug 2004. http:// bmj.com /cgi/eletters/329/7462/361#70955 , 14 Aug 2004

169) Geer MI, Koul PA, Tanki S, Adverse drug reactions monitoring in Kashmir. JK Practitioner (India) 2004;

170) Lone MA, Koul PA, Waheed A, Saleem SM, Iqbal J, Shah SU. Adenosine deaminase in pleural effusions in Kashmir. J Med Sciences (India) 2004;7(1):29-32.

171) Koul PA. Cushing’s syndrome following ‘Herbal therapies’ for Bronchial Asthma Rheumatoid Arthritis in India. Br Med J Feb 28, 2004. (http:// bmj.bmjjournals.com /cgi/eletters/328/7438/474#51792 )

172) Koul PA. HRT-Slow withdrawal or reduced dose may be necessitated. Br Med J (Feb17,2004) (http://bmj.bmjjournals.com/cgi/eletters/328/7436/371)

173) Koul PA, Wahid A, Bhat FA. Hemostasis in Rheumatoid Arthritis. Medicine Online (Priory.com) September 2003. (http://www.priory.com/med/ra.htm)

174) Koul PA, Wahid A, Hussain T, Wani JI, Ahmad T, Shah BA. Relapsing polychondritis in an elderly male. J Assoc Physicians India 2003;51:1105-6.

36

Page

18

175) Lone AR, Bhatt BA, Wafai ZA, Koul PA. TENS in osteoarthritis of the knee. Physiotherapy 2003;89(8):478-485.

176) Koul PA, Wahid A, Hussain T, Ahmad T. Thromboangitis obliterans in a young male. J Assoc Physicians India. 2003;51:590.

177) Tasleem RA, Bhat BA, Koul PA. Chronic low back pain- comparative analysis of treatment response to drugs and different physical modalities. JK Practitioner. 2003; 10(3):201-204.

178) Lone MA, Waheed A, Saleem SM, Koul PA, Bhat TA, Andrabi A. Pleural fluid alkaline phosphatse in various effusions. Ind J Chest Dis Allied Sci 2003 Jul-Sep;45(3):161-3.

179) Koul PA. Cystic Fibrosis in Kashmir. Hospital Administrator 2002;54:68-70.180) Koul PA, Wahid A, Shah BA. SLE presenting as distal renal tubular acidosis with

hypokalemic respiratory failure. Saudi J Kidney Dis Transplantation 2003;14 (2):190-193.

181) Koul PA. Typhoid vaccination N Engl J Med 2001 Aug 16;345(7):545-6. 182) Koul PA, Wahid A. Recurrent paralysis in a young man. The Lancet

2000;355:1612.183) Koul PA, Wahid A, Koul AN, Bhat FA, Shah SU, Saleem SM. Hypocomplementemic

urticarial vasculitis and lower cranial nerve palsies. J Assoc Physicians India 2000;48:536-7.

184) Koul PA, Koul AN, Wahid A, Mir FA. CT in pulmonary hydatid disease-Unusual appearances. CHEST( USA) 2000;118:1145-47.

185) Koul PA, Lone A, Hayat M, Koul AN. Foam Mattress Syndrome. J Assoc Physicians India 2000; 48:739-40. (Quoted extensively and included in the European Guidelines for Low Back Ache)

186) Koul PA, Wahid A, Wani JI, Hayat M. Mepacrine in niclosamide unresponsive Taeniasis. J Assoc Physicians India 2000;48:402-3.

187) Koul PA, Wahid A, Hayat M, Koul AN. Praziquantel in niclosamide resistant Taeniasis saginata. Scand J Infect Dis 1999;31(6):603-4.

37

Page

18

188) Wani GM, Ahmad M, Jan M, Koul PA, Masoodul Hassan. Mid Arm Circumference/head circumference ratio-parameter for identifying intrauterine growth retardation. JK Practitioner 1998; 5:204-205.

189) Koul PA. Doxycycline in sexually transmitted Diseases. Vibazine Rediscovered. 1999; 5:6.

190) Koul PA, Wahid A, Wani JI, Shah SU. Acinetobacter bacteremia presenting as community acquired pyrexial illness. J Assoc Physicians India 1998;46(12):1027-1028.

191) Koul PA, Koul AN, Wahid A, Jahangir M. Malignant mesothelioma at a young age. J Med Sciences 1998; 1:19-20.

192) Koul PA. Nephrotic syndrome and periodic paralysis. J Assoc Physicians India.1999;47:638

193) Koul PA, Koul AN, Wahid A. Cystic Fibrosis - An Often Missed diagnosis. JK Practitioner 1997;4:197-99.

194) Wahid A, Koul PA, Shah SU, Khan AR, Malik MA. Lead Exposure in Papier Machie Workers. Human & Experimental Toxicology (UK) 1997;16:281-283.

195) Bhat MS, Wani BA, Koul PA, Bisati SD, Wani JI. HLA tissue antigens in Kashmiri Muslims with Rheumatic Heart Disease. Ind J Med Research 1997;105:271-74.

196) Koul PA, Bhat D. Distal renal tubular acidosis and hypokalemic paralysis - Genetics and Precipitating factors. J Assoc Physicians India 1996;44:739-40.

197) Koul PA, Waheed A, Wani JI. Ciprofloxacin in multiresistant enteric fever in pregnancy. The Lancet 1995;307:397-8. (REFERENCED BY THE FDA, USA AS ONE EVIDENCE FOR USING CIPROFLOXACIN IN

TREATMENT OF ANTHRAX IN PREGNANCY…….. US FDA website on Cipro in pregnancy)

198) Koul PA, Waheed A. Polyangiitis overlap syndrome. JK Practitioner 1995;2:142-4.

38

Page

18

199) Koul PA, Pathania AGS, Malik GH, Riyaz T. Immunofluorescent Microscopic Patterns in nephrotic syndrome. JK Practitioner 1995;2:169-73

200) Koul PA, Waheed A, Mansoor K. A young man with muscle weakness and a mediastinal mass. JK Practitioner 1995;2:179-81.

201) Koul PA, Malik GH, Pathania AGS. Clinicopathological spectrum of nephrotic syndrome in Kashmir. JK Practitioner 1995;2:104-8.

202) Koul PA, Quadri MI, Wani JA, Waheed A, Shaban M. Haemostatic abnormalities in multidrug resistant enteric fever. Acta Haematologica 1995;93 (1):13-19. Abstracted in: Typhoid fever- Trend Setting Studies, 1996, p12.

203) Koul PA, Wahid A. Lung cyst in a young farmer. JK Practitioner 1995;2:118-9.

204) Koul PA Iqbal J, Waheed A. Guillian Barre syndrome related weakness in a case of periodic hypokalaemic paralysis. J Assoc Physicians India 1995; 43: 663.

205) Koul PA, Saleem SM, Bhat D. Sporadic distal renal tubular acidosis and periodic hypokalemic paralysis in Kashmir. J Intern Med (Acta Medica Scandinavica)(Sweden)1993; 233: 463-66.

206) Saleem SM, Koul PA. Chloramphenicol resistant typhoid fever complicated by disseminated intravascular coagulation and sensitive to ciprofloxacin. J Assoc Physicians India 1993; 41: 675-6.

207) Koul PA, Iqbal J, Waheed A, Shah PA, Aslam K. Malaria and Widal reaction. J Assoc Physicians India 1993; 41: 460-61.

208) Koul PA, Wani JA, Waheed A, Shah PA. Pulmonary manifestations of multidrug resistant typhoid fever. CHEST 1993; 144: 423-25.

209) Waheed A, Koul PA, Quadri MI, Iqbal J, Akhtar MA. Pure red cell aplasia complicating disseminated tuberculosis. Indian J Hematol Blood Transf 1993;11:40-42.

210) Koul PA, Saleem SM. Chronic active hepatitis with renal tubular acidosis presenting as hypokalemic periodic paralysis and respiratory failure. Acta Paed Scand 1992; 81: 568-9.

39

Page

18

(Abstracted in: Bone RC, et al. Year Book of Medicine 1994. CV Mosby, London .pp739-40).

211) Khuroo MS, Zargar SA, Yattoo GN, Koul PA, Alai MS. Ascaris Induced Acute Pancreatitis. Br J Surg1992; 79: 1335-38.

212) Khuroo MS, Zargar SA, Dar MY, Khan BA, Koul PA. Intrabiliary rupture of hepatic hydatid cysts: Sonographic and cholangiographic appearances Gastrointestinal Radiology 1992; 17: 41-45.

213) Malik GH, Sirwal IA, Pandit KA, Koul PA, Najar MS. Hemolytic uremic syndrome - experience at Srinagar (Kashmir). Indian Paediatrics 1990; 34: 1098-1100.

Review Articles/Editorials/Book Chapters

214) Malik GM, Koul PA. Assessment and management of Occupational risk of Hepatitis B in Health Care Professionals. JK Practitioner 1995;2:120-5.

215) Koul PA, Akhtar MA. Guidelines for treatment of Tuberculosis.Proceedings of the Update on Tuberculosis . 1996, pp1-12.

216) Koul PA, Munshi S. Effects of exposure to cold environment and exercise on Bronchial Asthma. JK Practitioner 1999;6:17-23.

217) Koul PA. Renal tubular acidosis- Current understanding with particular reference to the problem in Kashmir. Hospital Administrator 2002;54:35-40.

218) Koul PA. Pulmonary Hydatid Disease: Current Understanding. Proceedings of the 7th Joint Conference of Indian Chest Society & National College of Chest Physicians (I), Science City, Kolkatta. 2005;41-43.

219) Koul PA, Khan UH. Lung function in smokers. J Med Sci 2009;10:43-44.220) Koul PA. Influenza vaccination in healthcare workers, From slumber thou rise. J

Med Med Sci 2010;1(10)November:433-36.221) Koul PA. Pandemic H1N1: 180,000 and ticking… J Med Sci 2009;10:1-3

40

Page

18

222) Koul PA. Non-Invasive ventilation and exacerbations of COPD. (Editorial). J Medical Sciences 2008; 8(1): 1-2

223) Koul PA. Radiologically directed biopsy of lung masses.J Med Sciences 2004;7:23- 24

Book Chapters

224) Koul PA, Bali NK. Risk factors for Tuberculosis. In Jindal SK, ed. TextBook of Pulmonary And Critical Care Medicine. 2nd edition, 2017, Jaypee Brothers, New Delhi, p511-525.

225) Koul PA, Bali NK. Risk factors for Tuberculosis. In Jindal SK, ed. TextBook of Pulmonary And Critical Care Medicine. 2010, Jaypee Brothers, New Delhi, p511-525.

226) Koul PA, Khan UH. Pulmonary hydatid disease. Textbook of Respiratory Medicine. Academy of Respiratory Medicine, eds Shankar PS. 2013, Environment Society of India, Mumbai.

227) Koul PA, Khan UH. COPD in the elderly. Textbook of Geriatrics (in press) eds. Dr Pratap Sanchete (Indian Academy of Geriatrics)

228) Koul PA, Shah TH. Respiratory failure in the elderly. Textbook of Geriatrics (in press) eds. Dr Pratap Sanchete (Insdian Academy of Geriatrics)

Dissertation

229) Koul PA. Clinico-pathological spectrum of Nephrotic syndrome in Kashmir - a Hospital based study. Dissertation submitted to University of Institute of Medical Sciences, Srinagar - 1987).

Abstracts

41

Page

18

>400 abstracts published in various Conference Proceedings Including CHEST 2009-2016, ERS 2009-2016, ICEID, ROAD 2010, ERS 2008, NAPCON 2008, NAPCON 2007, NAPCON 2005, APICON 2005, 2004 and others.

REFERENCES

1. Dr. Harly Greenberg, MDDirector, Sleep Center Associate Professor, Pulmonary, Critical Care & Sleep Medicine,NorthShore Long Island Jewish Health System3300 Community Drive Manhasset, New York NY 11030 (USA) Email:greeber@lij.edu

2. Dr. G Saydain, MD, FACP, FCCP.Director, ICUPulmonary Critical Care and Sleep Div. Harper Univ Hops,3990 John R Street , 3-HudsonDetroit, 48201 MI , USA.Email: gsaydain@hotmail.com

3. Dr. Sunil Munshi, MD, DNB, MRCPConsultant Medicine & Geriatrics11, Fairfields Drive, Priory Wood, Ravensheaf NG 15 9HRUKEmail: sunil.munshi@nuh.nhs.uk.

42